NEOGEN CHEMICALS LIMITED
NEOGEN · General/Diversified · NSE
₹1,635
Current Market Price
Fair Value (DCF)
₹566
Margin of Safety
-65.4%
Updated just now
YieldIQ Score
45/100
Piotroski F-Score
3/9
Economic Moat
Narrow
Confidence
14%
ROE
—
Debt/Equity
1.41
WACC
11.1%
Market Cap
₹4,476 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
8.7%
Return on capital employed
EV / EBITDA
42.0×
Enterprise multiple
Debt / EBITDA
4.7×
Leverage vs earnings
Interest Coverage
2.3×
EBIT covers interest
Current Ratio
1.36×
Short-term liquidity
Asset Turnover
0.43×
Revenue per ₹ of assets
Revenue CAGR (3Y)
16.9%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,634.5
Bear case
₹328.71
MoS -397.2%
Base case
₹566.03
MoS -188.8%
Bull case
₹594.33
MoS -175.0%
Ratio Trends
NEOGEN · last 7 annual periods
ROE
4.4%
ROCE
8.4%
Operating Margin
—
Debt / Equity
0.76×
PE
237.1×
EV / EBITDA
32.5×
Historical Financials
NEOGEN · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹336 Cr | ₹487 Cr | ₹204 Cr | ₹200 Cr | ₹758 Cr | +22.5% |
| EBITDA | — | ₹86.6 Cr | ₹111 Cr | ₹113 Cr | ₹116 Cr | +7.5% |
| EBIT | ₹57.6 Cr | ₹76.0 Cr | ₹30.0 Cr | ₹32.1 Cr | — | -13.6% |
| PAT | ₹31.3 Cr | ₹44.6 Cr | ₹14.3 Cr | ₹16.9 Cr | ₹34.8 Cr | +2.7% |
| EPS (diluted) | ₹13.45 | ₹18.70 | ₹5.74 | ₹6.42 | — | -16.9% |
| CFO | ₹83.6 Cr | ₹1.4 Cr | ₹-30.4 Cr | ₹-29.1 Cr | ₹196 Cr | +23.7% |
| CapEx | — | — | — | — | ₹-318 Cr | — |
| FCF | — | — | — | — | ₹-122 Cr | — |
| Total Assets | — | ₹799 Cr | ₹1054 Cr | ₹1461 Cr | ₹1747 Cr | +21.6% |
| Total Debt | — | — | ₹233 Cr | ₹269 Cr | ₹597 Cr | +26.5% |
| Shareholders' Equity | — | — | ₹483 Cr | ₹760 Cr | ₹789 Cr | +13.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NEOGEN vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| INDIGOPNTS INDIGOPNTS | — | — | Pending | 13.8% | — |
| LXCHEM LAXMI ORGANIC INDUS LTD | -56.1% | 23 | Overvalued | 6.0% | — |
| VISHNU VISHNU | — | — | Pending | 13.7% | — |
| RESPONIND RESPONIND | — | — | Pending | 14.8% | — |
| POCL POCL | — | — | Pending | 9.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for NEOGEN in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of NEOGEN →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NEOGEN →
Compare
Head-to-head with peers
Compare NEOGEN side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NEOGENNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.